⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for recurrent adrenocortical carcinoma

Every month we try and update this database with for recurrent adrenocortical carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerNCT00005842
Cancer
trastuzumab
tipifarnib
18 Years - National Cancer Institute (NCI)
Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine FeaturesNCT01048892
Adrenocortical ...
Gastrointestina...
Kidney Cancer
Neuroblastoma
Retinoblastoma
Sarcoma
Seneca Valley v...
cyclophosphamid...
laboratory biom...
pharmacological...
3 Years - 21 YearsChildren's Oncology Group
Combination Chemotherapy and Tamoxifen in Treating Patients With Solid TumorsNCT00002608
Adrenocortical ...
Brain and Centr...
Head and Neck C...
Liver Cancer
Malignant Mesot...
Pheochromocytom...
Sarcoma
cisplatin
doxorubicin hyd...
tamoxifen citra...
conventional su...
radiation thera...
- 65 YearsNational Cancer Institute (NCI)
Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic CancerNCT00436410
Adrenocortical ...
Breast Cancer
Colorectal Canc...
Gastrointestina...
Kidney Cancer
Liver Cancer
Melanoma (Skin)
Ovarian Cancer
Pancreatic Canc...
Sarcoma
colloidal gold-...
electron micros...
pharmacological...
conventional su...
18 Years - National Institutes of Health Clinical Center (CC)
Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerNCT00005842
Cancer
trastuzumab
tipifarnib
18 Years - National Cancer Institute (NCI)
Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland CancerNCT00003453
Stage IV Adreno...
Antineoplaston ...
6 Months - 99 YearsBurzynski Research Institute
Gossypol Acetic Acid in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By SurgeryNCT00848016
Recurrent Adren...
Stage III Adren...
Stage IV Adreno...
R-(-)-gossypol ...
18 Years - National Cancer Institute (NCI)
Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine FeaturesNCT01048892
Adrenocortical ...
Gastrointestina...
Kidney Cancer
Neuroblastoma
Retinoblastoma
Sarcoma
Seneca Valley v...
cyclophosphamid...
laboratory biom...
pharmacological...
3 Years - 21 YearsChildren's Oncology Group
IMC-A12 With Mitotane vs Mitotane Alone in Recurrent, Metastatic, or Primary ACC That Cannot Be Removed by SurgeryNCT00778817
Recurrent Adren...
Stage III Adren...
Stage IV Adreno...
IMC-A12
mitotane
18 Years - National Cancer Institute (NCI)
Gossypol Acetic Acid in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By SurgeryNCT00848016
Recurrent Adren...
Stage III Adren...
Stage IV Adreno...
R-(-)-gossypol ...
18 Years - National Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: